- Home
- GLQ vs HBIO Comparison
GLQ vs HBIO Comparison
Compare GLQ & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLQ
- HBIO
- Stock Information
- Founded
- GLQ 2005
- HBIO 1901
- Country
- GLQ United States
- HBIO United States
- Employees
- GLQ N/A
- HBIO 416
- Industry
- GLQ Finance/Investors Services
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- GLQ Finance
- HBIO Industrials
- Exchange
- GLQ Nasdaq
- HBIO Nasdaq
- Market Cap
- GLQ 124.4M
- HBIO 106.4M
- IPO Year
- GLQ N/A
- HBIO 2000
- Fundamental
- Price
- GLQ $7.11
- HBIO $2.45
- Analyst Decision
- GLQ
- HBIO
- Analyst Count
- GLQ 0
- HBIO 0
- Target Price
- GLQ N/A
- HBIO N/A
- AVG Volume (30 Days)
- GLQ 65.5K
- HBIO 134.8K
- Earning Date
- GLQ 01-01-0001
- HBIO 11-05-2024
- Dividend Yield
- GLQ 11.11%
- HBIO N/A
- EPS Growth
- GLQ N/A
- HBIO N/A
- EPS
- GLQ N/A
- HBIO N/A
- Revenue
- GLQ N/A
- HBIO $101,125,000.00
- Revenue This Year
- GLQ N/A
- HBIO N/A
- Revenue Next Year
- GLQ N/A
- HBIO $2.68
- P/E Ratio
- GLQ N/A
- HBIO N/A
- Revenue Growth
- GLQ N/A
- HBIO N/A
- 52 Week Low
- GLQ $5.13
- HBIO $2.32
- 52 Week High
- GLQ $6.54
- HBIO $5.56
- Technical
- Relative Strength Index (RSI)
- GLQ 70.09
- HBIO 40.92
- Support Level
- GLQ $6.88
- HBIO $2.38
- Resistance Level
- GLQ $7.00
- HBIO $2.55
- Average True Range (ATR)
- GLQ 0.09
- HBIO 0.12
- MACD
- GLQ 0.02
- HBIO 0.00
- Stochastic Oscillator
- GLQ 62.50
- HBIO 31.71
About GLQ Clough Global Equity Fund Clough Global Equity Fund of Beneficial Interest
Clough Global Equity Fund is a closed-end management investment company. Its investment objective is to provide a high level of total return. The Fund invests in the equity, equity-related securities, and fixed-income securities in both U.S. and non-U.S. markets.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.